MedPath

Taichi for Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)

Not Applicable
Conditions
Polycystic Ovary Syndrome
Interventions
Behavioral: Taichi
Behavioral: Self-monitored exercise
Registration Number
NCT02608554
Lead Sponsor
Heilongjiang University of Chinese Medicine
Brief Summary

The present study is a randomized pilot study, overweight/obese adolescent and young PCOS subjects will be assigned into two groups: Taichi arm and control arm. Hormonal profile and metabolic profile will be determined.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • Women aged between 19 and 35 years;
  • Diagnosis of PCOS according to the modified Rotterdam criteria;
  • 2 years after menarche;
  • Body mass index (BMI) equal to or greater than 23 kg/m*m.
Exclusion Criteria
  • Administration of other medications known to affect reproductive function or metabolism within the past three months, including oral contraceptives, Gonadotropin-releasing hormone (GnRH) agonists and antagonists, anti androgens, gonadotropins, anti-obesity drugs, Chinese herbal medicines, anti diabetic drugs such as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel blockers.
  • Patients with other endocrine disorder including 21-hydroxylase deficiency, hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome.
  • Patients with known severe organ dysfunction or mental illness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TaichiTaichiThe 24 forms of simplified TCC recommended as the popular health sport by the General Administration of Sport of China were applied.
Self-monitored exerciseSelf-monitored exerciseExercise was self-monitored and consisted of brisk walking, cycling, jogging, or any other aerobic exercise.
Primary Outcome Measures
NameTimeMethod
Body mass index (BMI)3 months
Secondary Outcome Measures
NameTimeMethod
Testosterone (T)3 months
Follicle stimulating hormone (FSH)3 months
Fasting plasma glucose (Glu)3 months
Fasting insulin (Ins)3 months
HOMA-IR3 months

HOMA-IR = fasting insulin concentrations (mIU/L) ×fasting plasma glucose concentrations (mmol/L)/22.5

Ferriman-Gallwey score3 months
Luteinizing hormone (LH)3 months
Waist/hip ratio3 months

Trial Locations

Locations (1)

First Affiliated Hospital, Heilongjiang University of Chinese Medicine

🇨🇳

Harbin, Heilongjiang, China

© Copyright 2025. All Rights Reserved by MedPath